Novo Nordisk (NVO) – Trading Halts
-
Dicerna Pharma (DRNA) to be Acquired by Novo Nordisk (NVO) for $38.25/share, $3.3 Billion Deal
-
Strongbridge Biopharma (SBBP) Enters Agreement for Novo Nordisk (NVO) to Acquire U.S. and Canadian Rights to MACRILEN
-
-
Back to NVO Stock Lookup